Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market Expected to Grow Faster According to New Research Report 2023-2028

Report Overview

Indian Gastroesophageal Reflux Disease Therapeutics market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Gastroesophageal reflux disease (GERD) is defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications. The prevalence of GERD in India ranges from 7.6% to 30%, being < 10% in most population studies, and higher in cohort studies. The dietary factors associated with GERD include use of spices and non-vegetarian food. Helicobacter pylori is thought to have a negative relation with GERD; H. pylori negative patients have higher grade of symptoms of GERD and esophagitis. Less than 10% of GERD patients in India have erosive esophagitis. GERD is highly prevalent in southern India. Increasing age and BMI, an urban environment, lower educational level. Several factors such as increasing obesity, change in diet and lifestyle, smoking, and use of specific food types can affect the prevalence of GERD in this rapidly progressing society.The increasing prevalence of GERD, along with the growing risk factor population, is likely to increase the demand for proton pump inhibitors, which in turn, is expected to drive the market.

Market Drivers

The consumption of alcohol will affect the prevalence of gastroesophageal reflux disease. The increasing consumption of alcohol will affect the overall prevalence of the disease and could contribute to the overall market growth. Proton pump inhibitors are gold standard medication for gastroesophageal reflux disease (GERD), and the increasing prevalence of GERD and the rising acceptance of novel drug delivery systems are the two most prominent factors driving the growth of the market. The risk factors such as aging, obesity, delayed stomach emptying, changing lifestyles associated with smoking, consumption of alcohol, coffee, fatty, and fried foods are the major reasons for the occurrence of GERD.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/139654/

Major Players

Product launches and acquisitions are the key strategies adopted by the players in the Gastroesophageal Reflux Disease industry. The major players in Indian market are Tekeda Pharmaceutical Industries Ltd., AstraZeneca, Boston Scientific Corporation, Eisai Co., Ltd., Cheplapharm Arzneimittel GmbH, and Pfizer Inc.

The Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Indian Gastroesophageal Reflux Disease (GERD) Therapeutics market. This report explores all the key factors affecting the growth of the global Indian Gastroesophageal Reflux Disease (GERD) Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

To Know More About COVID-19 Impact On Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market @ https://www.prudentmarkets.com/sample-request/139654/

Market Segmentation

By Drug Type:

Based on the drug type the GERD Therapeutics Market is segmented into Antacid, H2 Receptor Blocker, Proton Pump Inhibitor, & Pro-Kinetic Agent. The major segment in drug type was held by antacids and is estimated to retain their top position over the forecast period. This is owing to the easy availability of antacid products in various forms such as in tablets, powders, and syrups. Proton pump inhibitors such as Omeprazole provides long-lasting reduction of stomach acid production. It initiates lower esophageal sphincter to close which prevents stomach acid to travel back into the bowel.

By Distribution Channel:

Based on distribution channel, the market for GERD Therapeutics Market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Major Players

Product launches and acquisitions are the key strategies adopted by the players in the Gastroesophageal Reflux Disease industry. The major players in Indian market are Tekeda Pharmaceutical Industries Ltd., AstraZeneca, Boston Scientific Corporation, Eisai Co., Ltd., Cheplapharm Arzneimittel GmbH, and Pfizer Inc.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/139654/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics
Chapter 4: Presenting the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/139654/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Indian Gastroesophageal Reflux Disease (GERD) Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.